Gene: ZBTB26
Official Full Name: zinc finger and BTB domain containing 26provided by HGNC
Gene Summary: Enables identical protein binding activity and sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Predicted to be located in nucleus. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12486 | ZBTB26 Knockout cell line (HeLa) | Human | ZBTB26 | 1:3~1:6 | Negative | Online Inquiry |
KO12487 | ZBTB26 Knockout cell line (HCT 116) | Human | ZBTB26 | 1:2~1:4 | Negative | Online Inquiry |
KO12488 | ZBTB26 Knockout cell line (HEK293) | Human | ZBTB26 | 1:3~1:6 | Negative | Online Inquiry |
KO12489 | ZBTB26 Knockout cell line (A549) | Human | ZBTB26 | 1:3~1:4 | Negative | Online Inquiry |
ZBTB26 Gene Knockout Cell Lines represent a specialized suite of experimental tools designed to investigate the biological roles of the ZBTB26 gene, which is implicated in various cellular processes, including transcription regulation and immune response modulation. These cell lines are created using CRISPR-Cas9 gene editing technology, enabling precise disruption of the ZBTB26 gene to elucidate its functions and uncover the molecular pathways it influences.
The key function of ZBTB26 Gene Knockout Cell Lines lies in their ability to facilitate a detailed analysis of the loss-of-function phenotypes associated with ZBTB26. Researchers can utilize these cell lines to study alterations in gene expression, cellular proliferation, and differentiation, as well as the modulation of signaling pathways linked to immune responses. The knockout of ZBTB26 provides insights into its role in human diseases such as autoimmune disorders and cancer, thereby contributing to the understanding of pathophysiological processes.
The scientific importance of these cell lines extends to applications in both basic research and clinical settings. In the laboratory, they can serve as valuable models for drug discovery initiatives, allowing scientists to assess the impact of pharmacological agents on cells lacking ZBTB26. In a clinical context, these cell lines may aid in identifying potential therapeutic targets while enhancing personalized medicine approaches.
One of the distinct advantages of ZBTB26 Gene Knockout Cell Lines over existing gene manipulation techniques is their specificity and efficiency in creating targeted knockouts without extensive off-target effects. This precision translates into more reliable experimental outcomes, ensuring that researchers can draw meaningful conclusions regarding the gene's biological significance.
For researchers, clinicians, and pharmaceutical developers, ZBTB26 Gene Knockout Cell Lines provide an indispensable resource that enables innovative research and therapeutic advancements. They are crafted by experts in genetic engineering and cell biology, ensuring high-quality, reproducible results. Our company has a strong commitment to producing cutting-edge biological products that empower scientists in their quest to unravel complex biological questions and contribute to the advancement of medical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.